The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder
Open accessThe DOI matches its Crossref record; 365 of the 365 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: These guidelines are based on a first edition that was published in 2004, and have been edited and updated with the available scientific evidence up to October 2012. Their purpose is to supply a systematic overview of all scientific evidence pertaining to the long-term treatment of bipolar disorder in adults. METHODS: Material used for these guidelines are based on a systematic literature search using various data bases. Their scientific rigor was categorised into six levels of evidence (A-F) and different grades of recommendation to ensure practicability were assigned. RESULTS: Maintenance trial designs are complex and changed fundamentally over time; thus, it is not possible to give an overall recommendation for long-term treatment. Different scenarios have to be examined separately: Prevention of mania, depression, or an episode of any polarity, both in acute responders and in patients treated de novo. Treatment might differ in Bipolar II patients or Rapid cyclers, as well as in special subpopulations. We identified several medications preventive against new manic episodes, whereas the current state of research into the prevention of new depressive episodes is less satisfactory. Lithium continues to be the substance with the broadest base of evidence across treatment scenarios. CONCLUSIONS: Although major advances have been made since the first edition of this guideline in 2004, there are still areas of uncertainty, especially the prevention of depressive episodes and optimal long-term treatment of Bipolar II patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–365 of 365
Lithium-carbamazepine neurotoxicity and risk factors
Shukla, S., Godwin, C. D., Long, L. E., & Miller, M. G. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.12.1604 · Cited by 112
SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study
Parker, G. B., Tully, L. A., Olley, A., & Hadži-Pavlović, D. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.01.024 · Cited by 112
Rybakowski, J. K., Chlopocka‐Wozniak, M., & Suwalska, A. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.030203.x · Cited by 111
Psychoeducation for bipolar II disorder: An exploratory, 5-year outcome subanalysis
Colom, F., Vieta, E., Sánchez‐Moreno, J., Goikolea, J. M., Popova, E., Bonnín, C. D. M., & Scott, J. L. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.023 · Cited by 111
Self-citationAsenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study
McIntyre, R. S., Cohen, M., Zhao, J., Alphs, L. D., Macek, T. A., & Panagides, J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.005 · Cited by 110
Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine
Passmore, M. J., Garnham, J., Duffy, A., MacDougall, M., Munro, A., Slaney, C., Teehan, A., & Alda, M. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00026.x · Cited by 109
Mood state at study entry as predictor of the polarity of relapse in bipolar disorder
Calabrese, J. R., Vieta, E., El‐Mallakh, R. S., Findling, R. L., Youngstrom, E. A., Elhaj, O., Gajwani, P., & Pies, R. W. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.022 · Cited by 108
Self-citationZimmerman, M., Martinez, J. A., Attiullah, N., Friedman, M., Toba, C., Boerescu, D. A., & Rahgeb, M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07203 · Cited by 108
A Review of Continuation and Maintenance Electroconvulsive Therapy
Rabheru, K., & Persad, E. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200503 · Cited by 106
Kovacsics, C. E., Gottesman, I. I., & Gould, T. D. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145557 · Cited by 106
Kessing, L. V., Hellmund, G., Geddes, J. R., Goodwin, G. M., & Andersen, P. K. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.084822 · Cited by 105 · cited 1×
“Such evidence, admittedly expensive and impractical in blinded trials, can be derived from national registry studies (Kessing et al 2011a), cohort and observational studies (Gitlin et al 1995) or pragmatic trials (Licht et al 2010).”
BackgroundSelf-citationRaucher‐Chéné, D., Charrel, C.-L., de Maindreville, A. D., & Limosin, F. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.05.022 · Cited by 105
Scott, J. L., Colom, F., Popova, E., Benabarre, A., Cruz, N., Valentí, M., Goikolea, J. M., Sánchez‐Moreno, J., Asenjo, M. Á., & Vieta, E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04333 · Cited by 105
Self-citationFindling, R. L., Youngstrom, E. A., McNamara, N., Stansbrey, R. J., Wynbrandt, J. L., Adegbite, C., Rowles, B. M., Demeter, C., Frazier, T. W., & Calabrese, J. R. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07104 · Cited by 104
Kemp, D. E., Gao, K., Ganocy, S. J., Elhaj, O., Bilali, S. R., Conroy, C., Findling, R. L., & Calabrese, J. R. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.07m04022 · Cited by 103
Loo, C. K. A., Katalinic, N., Mitchell, P. B., & Greenberg, B. D. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.017 · Cited by 103
Lithium Prophylaxis in Recurrent Affective Illness
Prien, R. F., Klett, C. J., & Caffey, E. M. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.2.198 · Cited by 103
Anticonvulsants in affective disorders.
Small, J. G. (1990) · PubMed · Cited by 103
Berwaerts, J., Melkote, R., Nuamah, I., & Lim, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.047 · Cited by 101
Magalhães, P. V. D. S., Dean, O. M., Bush, A. I., Copolov, D., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.001 · Cited by 101
The Effect of Carbamazepine and Lithium on Remission from Affective Illness
Watkins, S. E., Callender, K., Thomas, D. R., Tidmarsh, S. F., & Shaw, D. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.150.2.180 · Cited by 100
Vagus Nerve Stimulation: 2-Year Outcomes for Bipolar Versus Unipolar Treatment-Resistant Depression
Nierenberg, A. A., Alpert, J. E., Gardner-Schuster, E. E., Seay, S., & Mischoulon, D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.036 · Cited by 100
Bauer, M. S., Wisniewski, S. R., Marangell, L. B., Chessick, C. A., Allen, M. H., Dennehy, E. B., Miklowitz, D. J., Thase, M. E., Sachs, G. S., & STEP-BD Investigators (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0108 · Cited by 98
Esparon, J., Kolloori, J., Naylor, G. J., McHarg, A. M., Smith, A. H. W., & Hopwood, S. E. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.148.6.723 · Cited by 98
Commercial influence and the content of medical journals
Lexchin, J., & Light, D. W. (2006) · BMJ · doi:10.1136/bmj.332.7555.1444 · Cited by 97
Sixty Years of Lithium Responders
Grof, P. (2010) · Neuropsychobiology · doi:10.1159/000314305 · Cited by 95
Szegedi, A., Calabrese, J. R., Стет, Л., Mackle, M., Zhao, J., & Panagides, J. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f872f · Cited by 93
Quetiapine in the treatment of rapid cycling bipolar disorder
Vieta, E., Parramón, G., Padrell, E., Nieto, E., Martínez‐Arán, A., Corbella, B., Colom, F., Reinares, M., Goikolea, J. M., & Torrent, C. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01204.x · Cited by 92
Self-citationPreul, M. C., Leblanc, R., Caramanos, Z., et al. (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100033436 · Cited by 92
Antiepileptic drugs and suicidality
Britton, J. W., & Shih, J. J. (2010) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s13225 · Cited by 91
Vieta, E., Cruz, N., García‐Campayo, J., de Arce, R., Crespo, J. M., Vallès, V., Pérez‐Blanco, J., Roca, E., Olivares, J. M., Moríñigo, Á., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008596 · Cited by 90
Self-citationVieta, E., Goikolea, J. M., Martínez-Arán, A., Comes, M., Verger, K., Masramon, X., Sanchez-Moreno, J., & Colom, F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0320 · Cited by 89
Self-citationMania and depression. Mixed, not stirred
Pacchiarotti, I., Mazzarini, L., Kotzalidis, G. D., Valentí, M., Nivoli, A., Sani, G., Torrent, C., Murru, A., Sánchez‐Moreno, J., Patrizi, B., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.037 · Cited by 89
Self-citationDiscontinuation of Maintenance Treatment in Bipolar Disorder: Risks and Implications
Suppes, T. M., Baldessarini, R. J., Faedda, G. L., Tondo, L., & Tohen, M. F. (1993) · Harvard Review of Psychiatry · doi:10.3109/10673229309017072 · Cited by 89
Clozapine Prophylaxis in Rapid Cycling Bipolar Disorder
Calabrese, J. R., Meltzer, H. Y., & Markovitz, P. J. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199112000-00026 · Cited by 86
Annual cost of managing bipolar disorder to the UK healthcare system
Young, A. H., Rigney, U., Shaw, S., Emmas, C., & Thompson, J. M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.016 · Cited by 86
RAPID RECURRENCE OF MANIA FOLLOWING ABRUPT DISCONTINUATION OF LITHIUM
Mander, A. J., & Loudon, J. B. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92947-9 · Cited by 86
The empirical redefinition of the psychometric criteria for remission in bipolar disorder
Berk, M., Ng, F., Wang, W. V., Calabrese, J. R., Mitchell, P. B., Malhi, G. S., & Tohen, M. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.06.011 · Cited by 85
Licht, R. W., Vestergaard, P., Kessing, L. V., Larsen, J. K., & Thomsen, P. H. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s419.1.x · Cited by 85
Self-citationAntidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients
El‐Mallakh, R. S., Ghaemi, S. N., Sagduyu, K., Thase, M. E., Wisniewski, S. R., Nierenberg, A. A., Zhang, H. W., Pardo, T. A., & Sachs, G. S. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.025 · Cited by 85
Roijen, L. H., Hoeijenbos, M., Regeer, E. J., ten Have, M., Nolen, W. A., Veraart, C. P. W. M., & Rutten, F. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00403.x · Cited by 83
Licht, R. W., Nielsen, J. N., Gram, L. F., Vestergaard, P., & Bendz, H. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00836.x · Cited by 83
Self-citationRationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment.
Goodwin, F. K. (2002) · PubMed · Cited by 82
Altshuler, L. L., Post, R. M., Hellemann, G., Leverich, G. S., Nolen, W. A., Frye, M. A., Keck, P. E., Kupka, R. W., Grunze, H., McElroy, S. L., et al. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04191 · Cited by 81
Self-citationDuffy, A. C., Milin, R., & Grof, P. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-4 · Cited by 80
Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients
Valentí, M., Pacchiarotti, I., Rosa, A. R., Bonnín, C. M., Popovic, D., Nivoli, A. M. A., Murru, A., Grande, Í., Colom, F., & Vieta, E. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00908.x · Cited by 78
Self-citationGreil, W., Ludwig‐Mayerhofer, W., Erazo, N., Engel, R. R., Czernik, A., Giedke, H., Müller-Oerlinghausen, B., Osterheider, M., Rudolf, G. A. E., Sauer, H., et al. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02916252 · Cited by 78
Lithium Treatment Effects on the Neuropsychological Functioning of Patients With Bipolar I Disorder
López-Jaramillo, C., Lopera-Vásquez, J., Ospina-Duque, J., García, J., Gallo, A., Cortez, V., Palacio, C., Torrent, C., Martínez-Arán, A., & Vieta, E. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04673yel · Cited by 78
Self-citationNielsen, J., Kane, J. M., & Correll, C. U. (2012) · Bipolar Disorders · doi:10.1111/bdi.12018 · Cited by 78
Greil, W., & Kleindienst, N. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199909000-00002 · Cited by 77
Amsterdam, J. D., & Shults, J. (2005) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000171519.64080.c9 · Cited by 76
Extended-Release Carbamazepine Capsules as Monotherapy in Bipolar Disorder
Weisler, R. H., Hirschfeld, R. M. A., Cutler, A. J., Gazda, T. D., Ketter, T. A., Keck, P. E., Swann, A., & Kalali, A. H. (2006) · CNS Drugs · doi:10.2165/00023210-200620030-00004 · Cited by 76
Long-term risperidone treatment in bipolar disorder: 6-month follow up*
Ghaemi, S. N., & Sachs, G. S. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199711000-00006 · Cited by 76
Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: A report of three cases
Suppes, T. M., Phillips, K. A., & Judd, C. R. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90631-9 · Cited by 75
Olanzapine plus carbamazepinev.carbamazepine alone in treating manic episodes
Tohen, M. F., Bowden, C. L., Ab, S., Bergstrom, R. F., Quinlan, T., Osuntokun, O. O., Wang, W. V., Oliff, H. S., Martényi, F., Kryzhanovskaya, L. A., et al. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.041301 · Cited by 75
Self-citationGreil, W., & Kleindienst, N. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199909000-00003 · Cited by 74
A critical update on psychological interventions for bipolar disorders
Vieta, E., Pacchiarotti, I., Valentí, M., Berk, M., Scott, J. L., & Colom, F. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0075-0 · Cited by 74
Self-citationAntidepressants and Risks of Suicide and Suicide Attempts: A 27-Year Observational Study
Leon, A. C., Solomon, D. A., Li, C., Fiedorowicz, J. G., Coryell, W. H., Endicott, J., & Keller, M. B. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06552 · Cited by 74
Long-term use of valproate in primary psychiatric disorders.
Hayes, S. G. (1989) · PubMed · Cited by 74
Maj, M. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020202.x · Cited by 73
Adverse effects of prolactin in rodents and humans: breast and prostate cancer
Harvey, P. W., Everett, D. J., & Springall, C. J. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107082624 · Cited by 72
Vieta, E., Berk, M., Wang, W., Colom, F., Tohen, M. F., & Baldessarini, R. J. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.028 · Cited by 71
Self-citationBeynon, S., Soares‐Weiser, K., Woolacott, N. F., Duffy, S., & Geddes, J. R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093885 · Cited by 71
Grunze, H. (2008) · CNS Spectrums · doi:10.1017/s1092852900013912 · Cited by 68
Self-citationAnticonvulsants in bipolar disorder
Grunze, H. (2010) · Journal of Mental Health · doi:10.3109/09638230903469186 · Cited by 66
Self-citationvan der Loos, M. L. M., Mulder, P. G. H., Hartong, E. G. T. M., Blom, M. B. J., Vergouwen, A. C. M., van Noorden, M. S., Timmermans, M. A. Y., Vieta, E., Nolen, W. A., & for the LamLit Study Group* (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00887.x · Cited by 66
Self-citationTreatment of Rapid-Cycling Bipolar Disorder: Are Antidepressants Mood Destabilizers?
Ghaemi, S. N. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07121931 · Cited by 66
Verbal fluency in mania: relationship to number of manic episodes.
Lebowitz, B. K., Shear, P. K., Steed, M. A., & Strakowski, S. M. (2001) · PubMed · Cited by 66
Topiramate - Safety and Tolerability
Jones, M. W. (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100034855 · Cited by 65
Calabrese, J. R., Goldberg, J. F., Ketter, T. A., Suppes, T. M., Frye, M. A., White, R., DeVeaugh‐Geiss, A., & Thompson, T. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.034 · Cited by 64
Seo, H.-J., Chiesa, A., Lee, S.-J., Patkar, A. A., Han, C., Masand, P. S., Serretti, A., & Pae, C.-U. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182055c07 · Cited by 64
Carlson, B. X., Ketter, T. A., Sun, W., Timko, K., McQuade, R. D., Sanchez, R., Vester‐Blokland, E., & Marcus, R. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00974.x · Cited by 63
Vieta, E., Sánchez‐Moreno, J., Goikolea, J. M., Colom, F., Martínez‐Arán, A., Benabarre, A., Corbella, B., Torrent, C., Comes, M., Reinares, M., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000130556.01373.45 · Cited by 63
Self-citationOlanzapine: review of safety 2008
Kantrowitz, J. T., & Citrome, L. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802423234 · Cited by 63
Lithium in Neuropsychiatry - the Comprehensive Guide
Licht, R. W. (2006) · Cited by 62
Self-citationPerugi, G., Toni, C., Frare, F., Ruffolo, G., Moretti, L., Torti, C., & Akiskal, H. S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00008 · Cited by 61
Vieta, E., Nieto, E., Autet, A., Rosa, A. R., Goikolea, J. M., Cruz, N., & Bonet, P. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701530917 · Cited by 60
Self-citationDenicoff, K. D., Ali, S. O., Sollinger, A. B., Smith-Jackson, E. E., Leverich, G. S., & Post, R. M. (2002) · Depression and Anxiety · doi:10.1002/da.1078 · Cited by 59
Valproic acid amide in the treatment of affective and schizoaffective disorders
Puźyński, S., & Kłosiewicz, L. (1984) · Journal of Affective Disorders · doi:10.1016/0165-0327(84)90013-2 · Cited by 59
Task Force on Treatment Guidelines for Bipolar Disorders
Grunze, H., Kasper, S. F., Goodwin, G. W., Bowden, C. L., Baldwin, D., Licht, R. W., Vieta, E., & Möller, H.-J. (2002) · The World Journal of Biological Psychiatry · Cited by 58
Self-citationIncidence and Time Course of Subsyndromal Symptoms in Patients With Bipolar I Disorder
Frye, M. A., Yatham, L. N., Calabrese, J. R., Bowden, C. L., Ketter, T. A., Suppes, T. M., Adams, B. E., & Thompson, T. R. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1108 · Cited by 58
Self-citationValproate prophylaxis in a prospective clinical trial of refractory bipolar disorder
Denicoff, K. D., Smith‐Jackson, E. E., Bryan, A. L., Ali, O., & Post, R. M. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.10.1456 · Cited by 57
Muzina, D. J., Momah, C., Eudicone, J. M., Pikalov, A., McQuade, R. D., Marcus, R. N., Sanchez, R., & Carlson, B. X. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01735.x · Cited by 57
Bipolar depression: Clinical correlates of receiving antidepressants
Undurraga, J. P., Baldessarini, R. J., Valentí, M., Pacchiarotti, I., Tondo, L., Vázquez, G. H., & Vieta, E. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.027 · Cited by 56
Self-citationNolen, W. A., Kupka, R., Hellemann, G. S., Frye, M. A., Altshuler, L. L., Leverich, G. S., Suppes, T. M., Keck, P. E., McElroy, S. L., Grunze, H., et al. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.00993.x · Cited by 55
Self-citationBowden, C. L., Swann, A. C., Calabrese, J. R., McElroy, S. L., Morris, D. D., Petty, F., Hirschfeld, R. M. A., & Gyulai, L. (1997) · PubMed · Cited by 54
Self-citationExpanding the group of bipolar disorders
Marneros, A. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00349-9 · Cited by 54
Altamura, A. C. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00075-7 · Cited by 54
Teratogenesis associated with antibipolar agents
Nguyen, H. T., Sharma, V., & McIntyre, R. S. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0011-z · Cited by 54
Corya, S. A., Perlis, R. H., Keck, P. E., Lin, D., Case, M. G., Williamson, D. J., & Tohen, M. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0514 · Cited by 54
Baldessarini, R. J., Tondo, L., Hennen, J. A., & Floris, G. (1999) · Bipolar Disorders · doi:10.1034/j.1399-5618.1999.010206.x · Cited by 54
IJNP Editorial Board: Meeting new challenges
Lerer, B. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007498 · Cited by 54
Bipolar disorder in neurologic illness
Schneck, C. D. (2002) · Current Treatment Options in Neurology · doi:10.1007/s11940-002-0015-3 · Cited by 53
Vieta, E., Owen, R., Baudelet, C., McQuade, R. D., Sanchez, R., & Marcus, R. N. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003779380 · Cited by 52
Self-citationEffectiveness of Maintenance Electroconvulsive Therapy in Rapid-Cycling Bipolar Disorder
Minnai, G. P., Salis, P., Oppo, R., Loche, A. P., Scano, F., & Tondo, L. (2010) · Journal of Ect · doi:10.1097/yct.0b013e3181dbf797 · Cited by 52
Prophylactic effect of phenytoin in bipolar disorder: a controlled study
Mishory, A., Winokur, M., & Bersudsky, Y. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00070.x · Cited by 52
Tohen, M. F., Sutton, V. K., Calabrese, J. R., Sachs, G. S., & Bowden, C. L. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.003 · Cited by 50
Self-citationTural, Ü., & Önder, E. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02042.x · Cited by 50
More good news about the magic ion: lithium may prevent dementia
Young, A. H. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.082875 · Cited by 49
Kessing, L. V., Hellmund, G., & Andersen, P. K. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111414091 · Cited by 48
Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change
Martínez‐Arán, A., Vieta, E., Chengappa, K. R., Gershon, S., Mullen, J., & Paulsson, B. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00611.x · Cited by 48
Self-citationLithium treatment — moderate dose use study (LiTMUS) for bipolar disorder: rationale and design
Nierenberg, A. A., Sylvia, L. G., Leon, A. C., Reilly-Harrington, N. A., Ketter, T. A., Calabrese, J. R., Thase, M. E., Bowden, C. L., Friedman, E. S., Ostacher, M. J., et al. (2009) · Clinical Trials · doi:10.1177/1740774509347399 · Cited by 48
Self-citationBallenger, J. C. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2012.06.053 · Cited by 48
Reducing the Risk for Suicide in Schizophrenia and Affective Disorders
Meltzer, H. Y., & Baldessarini, R. J. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0920 · Cited by 48
Goldberg, J. F., Bowden, C. L., Calabrese, J. R., Ketter, T. A., Dann, R. S., Frye, M. A., Suppes, T. M., & Post, R. M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.031 · Cited by 47
Self-citationYoung, A. H., McElroy, S. L., Olausson, B., Paulsson, B., (D1447C00001), O. B. O. T. E. I., & Embolden II (D1447C00134) Investigators (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.665177 · Cited by 46
Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
Fountoulakis, K. Ν., & Vieta, E. (2009) · Annals of General Psychiatry · doi:10.1186/1744-859x-8-16 · Cited by 46
Self-citationSuppes, T. M., Brown, E., Schuh, L. M., Baker, R. W., & Tohen, M. F. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.011 · Cited by 45
Grande, I., de Arce, R., Jiménez‐Arriero, M. Á., Lorenzo, F. G. I., Valverde, J. I. F., Balanzá‐Martínez, V., Domingo, S. Z., Cobaleda, S., & Vieta, E. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000405 · Cited by 45
Self-citationQuitkin, F. M., Rifkin, A. E., Kane, J. M., Ramos-Lorenzi, J. R., & Klein, D. F. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.5.570 · Cited by 45
Recovery and functional outcomes following olanzapine treatment for bipolar I mania
Chengappa, K. R., Hennen, J. A., Baldessarini, R. J., Kupfer, D. J., Yatham, L. N., Gershon, S., Baker, R. W., & Tohen, M. F. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00171.x · Cited by 44
Carbamazepine in Rapid Cycling Bipolar Affective Disorder
Joyce, P. R. (1988) · International Clinical Psychopharmacology · doi:10.1097/00004850-198804000-00003 · Cited by 44
Head to head comparisons as an alternative to placebo-controlled trials
Vieta, E., & Cruz, N. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.11.011 · Cited by 44
Self-citationDefining and achieving recovery from bipolar disorder.
Harvey, P. D. (2006) · PubMed · Cited by 43
The clinical use of gabapentin in bipolar spectrum disorders
Carta, M. G., Hardoy, M. C., Hardoy, M. J., Grunze, H., & Carpiniello, B. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00046-0 · Cited by 43
Self-citationLicht, R. W., Vestergaard, P., & Brodersen, A. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00499.x · Cited by 42
Self-citationDepot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients
Malempati, R. N., Bond, D. J., & Yatham, L. N. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282f2b4c5 · Cited by 41
Lithium Plus Valproate as Maintenance Polypharmacy for Patients With Bipolar I Disorder: A Review
Solomon, D. A., Keitner, G. I., Ryan, C. E., & Miller, I. W. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199802000-00007 · Cited by 40
Severus, W. E., Kleindienst, N., Evoniuk, G. E., Bowden, C. L., Möller, H. ‐., Bohus, M., Frangou, S., Greil, W., & Calabrese, J. R. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.009 · Cited by 39
Self-citationEvidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations
Möller, H., & Maier, W. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0070-9 · Cited by 39
Self-citationClozapine in Rapid Cycling Bipolar Disorder
Frye, M. A., Altshuler, L. L., & Bitran, J. A. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199602000-00022 · Cited by 39
Woo, Y. S., Bahk, W., Chung, M. Y., Kim, D., Yoon, B., Lee, J. H., Ahn, Y. M., Chung, S., Kim, J., Lee, K. H., et al. (2011) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1240 · Cited by 38
The safety and tolerability of atypical antipsychotics in bipolar disorder
Seemüller, F., Forsthoff, A., Dittmann, S., Born, C., Bernhard, B., Severus, W. E., & Grunze, H. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.5.849 · Cited by 38
Self-citationJährliche Krankheitskosten bipolarer Störungen in Deutschland
Runge, C., & Grunze, H. (2004) · Der Nervenarzt · doi:10.1007/s00115-004-1691-x · Cited by 37
Self-citationVieta, E., Suppes, T., Ekholm, B., Udd, M., & Gustafsson, U. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.014 · Cited by 37
Self-citationMendel, E. (1908) · Cited by 36
Johnstone, E. C., Owens, D. G. C., Lambert, M. T., Crow, T. J., Frith, C., & Done, D. J. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90054-c · Cited by 35
Elphick, M. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.147.2.198 · Cited by 35
Aripiprazole for the maintenance treatment of bipolar I disorder: A review
McIntyre, R. S. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.01.022 · Cited by 32
Han, C., Lee, M., Pae, C., Ko, Y., Patkar, A. A., & Jung, I. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.04.017 · Cited by 31
Riemann, D. W., Gann, H., Hohagen, F., et al. (2008) · Neuropsychobiology · doi:10.1159/000118974 · Cited by 30
Clozapine as Add-On Medication in the Maintenance Treatment of Bipolar and Schizoaffective Disorders
Hummel, B., Dittmann, S., Forsthoff, A., Matzner, N., Amann, B. L., & Grunze, H. (2002) · Neuropsychobiology · doi:10.1159/000049260 · Cited by 30
Self-citationPredicting Response to Lithium in Mood Disorders: Role of Genetic Polymorphisms
Serretti, A., & Artioli, P. (2003) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200303010-00004 · Cited by 29
Bowden, C. L., Singh, V., Weisler, R. H., Thompson, P., Chang, X., Quinones, M., & Mintz, J. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01890.x · Cited by 28
Self-citationA Clinician’s Guide to Monitoring Kidney Function in Lithium-Treated Patients
Jefferson, J. W. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05917yel · Cited by 27
Kleindienst, N., Severus, W. E., & Greil, W. (2007) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000224788.21406.c8 · Cited by 26
Ketter, T. A., Jones, M., & Paulsson, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.006 · Cited by 26
Antiepileptic drugs and suicidality
Fountoulakis, K. Ν., Gonda, X., Samara, M. T., Siapera, M., Karavelas, V., Ristić, D. I., & Iacovides, A. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112440514 · Cited by 25
Differential modulation of intracellular Ca2+ responses in B lymphoblasts by mood stabilizers
Perova, T., Kwan, M., Li, P. P., & Warsh, J. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000261 · Cited by 25
[Carbamazepine in manic syndromes. A controlled double-blind study].
Gonçalves, N., & Kd, S. (1985) · PubMed · Cited by 24
Use of quetiapine in bipolar disorder: a case series with prospective evaluation
Suppes, T. M., McElroy, S. L., Keck, P. E., Altshuler, L. L., Frye, M. A., Grunze, H., Leverich, G. S., Nolen, W. A., Chisholm, K., Dennehy, E. B., et al. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200405000-00010 · Cited by 23
Self-citationSeverus, W. E., Lipkovich, I. A., Licht, R. W., Young, A. H., Greil, W., Ketter, T. A., Deberdt, W. G., & Tohen, M. F. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2009.10.009 · Cited by 22
Self-citationKeck, P. E., Bowden, C. L., Meinhold, J. M., Gyulai, L., Prihoda, T. J., Baker, J. D., & Wozniak, P. J. (2005) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500500305622 · Cited by 22
Self-citationEpidemiologic study of aripiprazole use and the incidence of suicide events
Ulcickas Yood, M., DeLorenze, G., Quesenberry, C. P., Tsai, A., Phillips, S., Willey, V. J., Niemcryk, S. J., Wells, K., Skovron, M. L., Cziraky, M. J., et al. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2047 · Cited by 22
Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder
McElroy, S. L., Bowden, C. L., Collins, M. A., Wozniak, P. J., Keck, P. E., & Calabrese, J. R. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.08.014 · Cited by 21
Self-citationKemp, D. E., Karayal, O. N., Calabrese, J. R., Sachs, G. S., Pappadopulos, E. A., Ice, K. S., SIU, C. O., & Vieta, E. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.06.005 · Cited by 19
Self-citationGonzález-Pinto, A. M., Vieta, E., Reed, C. C., Novick, D., Barraco, A., Aguado, J., & Haro, J. M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.037 · Cited by 19
Self-citationMeta-analyses: a method to maximise the evidence from clinical studies?
Maier, W., & Möller, H. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0068-3 · Cited by 19
Self-citationQuitkin, F. M., Kane, J. M., Rifkin, A. E., Ramos-Lorenzi, J. R., Saraf, K. R., Howard, A., & Df, K. (1981) · PubMed · Cited by 19
Some Practical Aspects of Lithium Treatment
Grof, P. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780080065015 · Cited by 18
Newer Prophylactic Agents for Bipolar Disorder and Their Influence on Suicidality
Born, C., Dittmann, S., Post, R. M., & Grunze, H. (2005) · Archives of Suicide Research · doi:10.1080/13811110590929541 · Cited by 18
Self-citationMurru, A., Colom, F., Nivoli, A., Pacchiarotti, I., Valentí, M., & Vieta, E. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2010.09.012 · Cited by 17
Self-citationBenabarre, A., Castro, P., Sánchez‐Moreno, J., Martínez‐Arán, A., Salamero, M., Murru, A., Franco, C., & Vieta, E. (2009) · Actas Españolas de Psiquiatría · Cited by 15
Self-citationGrande, I., Balanzá‐Martínez, V., Jiménez-Arriero, M., Lorenzo, F. G. I., Valverde, J. I. F., de Arce, R., Domingo, S. Z., Cobaleda, S., & Vieta, E. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.035 · Cited by 15
Self-citationPark, M.-H., Han, C., Pae, C., Lee, S.-J., Patkar, A. A., Masand, P. S., & Fleischhacker, W. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.151 · Cited by 14
Improving the design of maintenance studies for bipolar disorder
Gitlin, M. J., Abulseoud, O. A., & Frye, M. A. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.489830 · Cited by 14
Suppes, T. M., Kelly, D. I., Keck, P. E., McElroy, S. L., Altshuler, L. L., Mintz, J., Frye, M. A., Nolen, W. A., Luckenbaugh, D. A., Post, R. M., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3281c55f63 · Cited by 13
Self-citationOlanzapine/fluoxetine combination for bipolar depression
Shelton, R. C. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.1.33 · Cited by 13
Assessments of Suicidality in Double-Blind, Placebo-Controlled Trials of Ziprasidone
Karayal, O. N., Anway, S. D., Batzar, E. D., & Vanderburg, D. G. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06281gre · Cited by 11
Kelly, D. I., Suppes, T. M., Keck, P. E., McElroy, S. L., Altshuler, L. L., Frye, M. A., Nolen, W. A., Kupka, R., Grunze, H., Leverich, G. S., et al. (n.d.) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 10
Self-citationOn variability of effects for a metaanalysis of rheumatoid arthritis radiographic progression.
Anderson, J. (2000) · PubMed · Cited by 8
Antiepileptic drugs and suicide
Trimble, M. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977145.014 · Cited by 7
Ziprasidone for maintenance treatment of bipolar I disorder in adults
Dubovsky, S. L., & Dubovsky, A. N. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.563237 · Cited by 5
Report of three cases that received maintenance treatment with risperidone as a mood stabilizer
Fountoulakis, K. Ν., Nimatoudis, I., Iacovides, A., & KAPRINIS, G. S. (2004) · Annals of General Hospital Psychiatry · doi:10.1186/1475-2832-3-10 · Cited by 5
Bayesian approach to bipolar guidelines
Belmaker, R. H., Bersudsky, Y., & Lichtenberg, P. (2009) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903414196 · Cited by 3
Research works printed but not linked: 53
- Abou-Auda HS, 2008, Bipolar Disord, 10, 369, 10.1111/j.1399-5618.2007.00549.x · doi:10.1111/j.1399-5618.2007.00549.x
- Agarkar S, 2011, J Neuropsychiatry Clin Neurosci, 23, 12, 10.1176/jnp.23.2.jnpe12 · doi:10.1176/jnp.23.2.jnpe12
- Anderson J, 2000, J Rheumatol, 27, 540
- Angst J, 1981, Handbook of Biological Psychiatry, 225
- Angst J, 1995, Schweiz Arch Neurol Psychiatr, 146, 17
- Becker D, 2002, Eur Psychiatry, 17, 349, 10.1016/S0924-9338(02)00688-0 · doi:10.1016/s0924-9338(02)00688-0
- Benabarre A, 2009, Actas Esp Psiquiatr, 37, 143
- Bowden CL, 1997, Psychopharmacol Bull, 33, 693
- Bowden CL, 2012, Acta Psychiatry, 64, 1013
- Calabrese J, 2003, J Clin
- Carta MG, 2006, Clin Pract Epidemiol Ment Health, 2, 19, 10.1186/1745-0179-2-19 · doi:10.1186/1745-0179-2-19
- Dunner DL, 1998, J Clin Psychiatry, 59, 48
- Emrich HM, 1992, Prog Neuropsychopharmacol Biol Psychiatry, 16, 691, 10.1016/0278-5846(92)90025-A · doi:10.1016/0278-5846(92)90025-a
- Ernst CL, 2002, J Clin Psychiatry, 63, 42
- Fitzgerald BJ, 2002, Pharmacotherapy, 22, 1500, 10.1592/phco.22.16.1500.33697 · doi:10.1592/phco.22.16.1500.33697
- Garcia-Lopez A, 2001, Actas Esp Psiquiatr, 29, 327
- Ghaemi SN, 2004, Ann Clin Psychiatry, 16, 69, 10.1080/10401230490453103 · doi:10.1080/10401230490453103
- Ghaemi SN, 2006, Psychiatr Serv, 57, 660, 10.1176/ps.2006.57.5.660 · DOI · Paper page
- 10.4088/JCP.08m04301 · DOI
- Goncalves N, 1985, Nervenarzt, 56, 43
- Goodwin FK, 2002, J Clin Psychiatry, 63, 5
- Grande I, 2012, Int J Neuropsychopharmacol, 1
- Greil W, 1999, Int Clin Psychopharmacol, 14, 283, 10.1097/00004850-199914050-00003 · DOI
- Greil W, 1999, Int Clin Psychopharmacol, 14, 277, 10.1097/00004850-199914050-00002 · DOI
- Grunze H, 2004, Valproat bei manisch-depressiven (bipolaren) Erkrankungen
- Harvey PD, 2006, J Clin Psychiatry, 67, 14
- Hayes SG, 1989, J Clin Psychiatry, 50, 35
- Hullin RP, 1972, Lancet i, 1044
- Kessing LV, 2011, J Psychopharmacol
- Lancon C, 1996, Encephale, 22, 468
- Lebowitz BK, 2001, Neuropsychiatry Neuropsychol Behav Neurol, 14, 177
- Moskowitz AS, 1991, J Clin Psychopharmacol, 11, 272, 10.1097/00004714-199108000-00020 · doi:10.1097/00004714-199108000-00020
- Murru A, 2011, Eur Psychiatry
- Nolen WA, 2008, Richtlijn bipolaire stoornissen
- Placidi GF, 1986, J Clin Psychiatry, 47, 490
- Popovic D, 2011, Eur Neuropsychopharmacol
- Puri BK, 1995, Br J Clin Pract, 49, 333, 10.1111/j.1742-1241.1995.tb10004.x · doi:10.1111/j.1742-1241.1995.tb10004.x
- Puzynski S, 1984, Psychopharmacol Bull, 20, 151
- Quitkin FM, 1981, Psychopharmacol Bull, 17, 142
- Riedel M, 2010, Expert Opin Drug Saf, 9, 659, 10.1517/14740338.2010.486787 · doi:10.1517/14740338.2010.486787
- Sachdev PS, 1986, Am J Psychiatry, 143, 942, 10.1176/ajp.143.7.942 · doi:10.1176/ajp.143.7.942
- Sachs GS, 2000, Postgrad Med Spec Report, 1
- Sartorius N, 2007, Int J Neuropsychopharmacol, 10, 1
- Singh V, 2012, Bipolar Disord, 14, 13
- Szabo CP, 1993, S Afr Med J, 83, 442
- Vieta E, 2011, New Engl J Med, 364, 1581
- 10.1016/j.jad.2009.02.028 · DOI
- Viguera AC, 2007, J Clin Psychiatry, 68, 29
- World Health Organization, 1992, Clinical descriptions and diagnostic guidelines
- Yoshimura R, 2006, Pharmacopsychiatry, 39, 233, 10.1055/s-2006-951386 · doi:10.1055/s-2006-951386
- Young AH, 2012, World J Biol Psychiatry
- Zarate CA, 1995, J Clin Psychiatry, 56, 108
- Zis AP, 1980, Psychopharmacol Bull, 16, 47
Cited by
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Self-citationMalhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Mobile Apps for Bipolar Disorder: A Systematic Review of Features and Content Quality
Nicholas, J., Larsen, M. E., Proudfoot, J., & Christensen, H. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4581 · Cited by 438
“It is recommended to check every 3-6 months” Grunze et al, 2013, pp 186 [18] 7.”
Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Seeman, M., et al. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s117321 · Cited by 438
Self-citationLithium and suicide in mood disorders: Updated meta‐review of the scientific literature
Smith, K. A., & Cipriani, A. (2017) · Bipolar Disorders · doi:10.1111/bdi.12543 · Cited by 247
Metadata
- Authors
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2013-03-13
- Volume
- 14
- Issue
- 3
- Pages
- 154-219
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2170882187
- Cited by
- 421
- References
- 365
- FWCI
- 31.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.